Xebra Brands Stock Price, News & Analysis

Xebra Brands Ltd. (CSE: XBRA) (OTCQB: XBRAF) announces that its Vicious Citrus cannabis-infused lemonade has been accepted by the Ontario Cannabis Store (OCS) for sale in Ontario, Canada. This beverage combines 10mg of THC with 2mg of CBN and is among the few Canadian products containing CBN. Marketing efforts will commence ahead of its commercial production scheduled for June 20, with availability expected in summer 2022. Xebra's lemonade is noted for its emulsion technology, which underwent Phase I clinical trials, highlighting its commitment to product safety and quality.

Xebra Brands Ltd. (CSE: XBRA, OTCQB: XBRAF) announced the successful closing of its oversubscribed non-brokered private placement, raising C$1,800,000 through the issuance of 15,000,000 units priced at C$0.12 each. Each unit includes one common share and a half warrant, with full warrants allowing the purchase of a share at C$0.25 for 12 months. The company will use proceeds for general working capital.

The private placement is subject to a hold period expiring on August 9, 2022.

Xebra Brands Ltd. (CSE: XBRA) (OTCQB: XBRAF) has successfully harvested its first cannabis crop in the Netherlands, comprised of high THC and THC-CBD balanced flowers. The samples were submitted to the Bureau of Medicinal Cannabis on March 25, 2022. As one of five companies selected for a Dutch government pilot trial, Xebra aims to secure one of two licenses, potentially generating at least ~US$80 million in guaranteed revenue. Further crops are planned for submission, with the next deadline set for September 19, 2022, and a decision on licenses expected by April 3, 2023.

Xebra Brands Ltd. (CSE: XBRA) has secured a significant milestone with the Supreme Court of Mexico issuing a final resolution granting an injunction to its subsidiary, Desart MX, SA de CV. This decision solidifies Xebra's first-mover advantage in the emerging Mexican cannabis market, particularly in the industrial cannabis sector, focusing on low-THC products. Following previous unanimous support from the Supreme Court, the company aims to initiate formal cannabis operations within 2022, leveraging Mexico's potential as a major cannabis consumer market and its favorable manufacturing costs compared to North America.

Xebra Brands Ltd. (CSE: XBRA) (OTCQB: XBRAF) (FSE: 9YC) has announced that its cannabis cultivation in the Netherlands is in the flowering stage, with samples to be submitted to Dutch authorities by the end of March. As one of five select companies in a government pilot trial, Xebra aims to secure one of two licenses, potentially generating revenues of up to ~US$80 million over six years. The company emphasizes automation in cultivation for consistent quality, with its operations led by industry expert Harry von Duijne, previously with Bedrocan NL.

Xebra Brands Ltd. (CSE: XBRA, OTCQB: XBRAF) announced plans to launch its cannabis beverage, Vicious Citrus Lemonade, in Canada, targeting Alberta, British Columbia, and Ontario. This beverage contains 10mg of THC and 2mg of CBN per serving, offering a unique consumption experience due to the synergistic effects of cannabinoids. Vicious Citrus Lemonade is notably among the few beverages with CBN in Canada and utilizes tested emulsion IP. Production is set to start in spring 2022, aiming for a summer launch, with positive feedback from provinces and dispensaries noted.

Xebra Brands Ltd. (CSE: XBRA) (OTCQB: XBRAF) has achieved eligibility for DTC services, enhancing the liquidity of its shares for U.S. investors. This development simplifies the trading process and reduces costs for investors and brokers, allowing wider access to Xebra's shares. President Rodrigo Gallardo noted this as a significant milestone in increasing corporate visibility and facilitating U.S. investment in the company. DTC serves as a clearinghouse for electronically traded securities in the U.S., streamlining settlements.

Xebra Brands Ltd. (CSE: XBRA, OTCQB: XBRAF) announces a non-brokered private placement aiming for gross proceeds of up to CAD$1,200,000. The offering consists of up to 10,000,000 units priced at CAD$0.12 per unit, each unit containing one common share and a half warrant. Each full warrant can be exercised to buy a common share at CAD$0.25 for 12 months. The proceeds will be allocated for general working capital. The placement is subject to Canadian Securities Exchange approval.

Xebra Brands Ltd. (CSE: XBRA) has announced the granting of trademarks for its cannabis-infused beverage brands in various Latin American countries, including Argentina, Brazil, and Colombia. The trademarks include names such as MADCAP for soft drinks and VICIOUS CITRUS for lemonades, along with catchy slogans. This move supports Xebra's strategy to secure global trademark protection as cannabis legalization expands. The company is also focused on launching its products in Canada and completing agronomical evaluations in Colombia for future cannabis activities.